UnitedHealth Group Incorporated
UNHNYSE
$423.71
Last price · USD
- Market cap
- $385.6B
- P/E
- 32.0x
- EV / EBITDA
- 19.1x
- P/S
- 0.9x
- FCF yield
- 4.2%
- Div. yield
- 2.05%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
UnitedHealth Group Incorporated key metrics & ratios
Annual · USD millions except per-share data · 35 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Growth (year over year) | |||||||
| Revenue growth | 11.8% | 7.7% | 14.6% | 12.7% | — | — | |
| Operating income growth | -41.3% | -0.2% | 13.8% | 18.6% | — | — | |
| Net income growth | -16.3% | -35.6% | 11.2% | 16.4% | — | — | |
| EPS (diluted) growth | -14.7% | -35.0% | 12.7% | 17.1% | — | — | |
| Free cash flow growth | -22.4% | -19.4% | 9.7% | 17.7% | — | — | |
| Margins | |||||||
| Gross margin | 18.5% | 22.3% | 24.5% | 24.6% | 24.2% | — | |
| Operating margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | — | |
| EBITDA margin | 5.2% | 7.0% | 9.8% | 9.8% | 9.4% | — | |
| Net margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | — | |
| FCF margin | 3.6% | 5.2% | 6.9% | 7.2% | 6.9% | — | |
| Returns on capital | |||||||
| Return on equity | 12.8% | 15.5% | 25.2% | 25.9% | 24.1% | — | |
| Return on assets | 3.9% | 4.8% | 8.2% | 8.2% | 8.1% | — | |
| Return on invested capital | 11.2% | 17.0% | 19.7% | 19.9% | 19.8% | — | |
| Leverage & liquidity | |||||||
| Debt / equity | 0.83x | 0.83x | 0.76x | 0.74x | 0.64x | — | |
| Net debt / EBITDA | 2.34x | 1.84x | 1.16x | 1.08x | 0.91x | — | |
| Current ratio | 0.79x | 0.83x | 0.79x | 0.77x | 0.79x | — | |
| Interest coverage | 4.74x | 8.27x | 9.97x | 13.59x | 14.44x | — | |
| Profitability & operating | |||||||
| EBIT | 18,699 | 23,977 | 32,358 | 28,435 | 23,970 | -6.0% | |
| EBITDA | 23,060 | 28,076 | 36,330 | 31,835 | 27,073 | -3.9% | |
| Operating income | 18,964 | 32,287 | 32,358 | 28,435 | 23,970 | -5.7% | |
| Income before tax | 14,697 | 20,071 | 29,112 | 26,343 | 22,310 | -9.9% | |
| Net income | 12,056 | 14,405 | 22,381 | 20,120 | 17,285 | -8.6% | |
| Earnings per share | |||||||
| EPS (basic) | $13.23 | $15.64 | $24.12 | $21.54 | $18.33 | -7.8% | |
| EPS (diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | -7.5% | |
| Share count (millions) | |||||||
| Weighted avg shares outstanding | 910 | 929 | 928 | 934 | 943 | -0.9% | |
| Weighted avg shares outstanding (diluted) | 910 | 929 | 938 | 950 | 956 | -1.2% | |
| Balance sheet highlights | |||||||
| Net debt | 54,024 | 51,592 | 42,008 | 34,258 | 24,628 | +21.7% | |
| Total debt | 78,389 | 76,904 | 67,435 | 57,623 | 46,003 | +14.3% | |
| Total investments | 58,007 | 56,155 | 51,810 | 48,274 | 45,646 | +6.2% | |
| Total stockholders' equity | 94,110 | 92,658 | 88,756 | 77,772 | 71,760 | +7.0% | |
| Total assets | 309,581 | 298,278 | 273,720 | 245,705 | 212,206 | +9.9% | |
| Cash flow highlights | |||||||
| Free cash flow | 16,075 | 20,705 | 25,682 | 23,404 | 19,889 | -5.2% | |
| Operating cash flow | 19,697 | 24,204 | 29,068 | 26,206 | 22,343 | -3.1% | |
| Capital expenditure | (3,622) | (3,499) | (3,386) | (2,802) | (2,454) | — | |
| Net cash from operating activities | 19,697 | 24,204 | 29,068 | 26,206 | 22,343 | -3.1% | |